感染監視ソリューション市場- 世界の産業規模、シェア、動向、機会、予測、2018～2028年、オファリング別、エンドユーザー別、地域別、競合

感染監視ソリューションの世界市場は、2022年に5億5,721万米ドルの評価額に達し、予測期間には堅調な成長が見込まれており、年間平均成長率（CAGR）は11.16％、2028年には10億5,198万米ドルに達すると予測されています。

感染サーベイランスソリューションは、病院を含む医療施設が患者データを州および連邦当局に報告するために利用するソフトウェアです。これらのソリューションは、院内感染に関するデータを収集し、感染パターンを研究し、コミュニティ内での感染拡大を規制することで、医療業界で重要な役割を果たしています。院内感染とは、病院や医療センター内で個人に感染する感染症のことです。このソフトウェアは、感染症が発生した場合に病院のインターネットプロトコル（IP）アドレスに迅速に警告を発し、HAI専門医や看護師が感染した患者に適切な治療を迅速に提供することを可能にし、感染症の発生を予防します。感染監視ソリューションは、医療施設における医療感染症（HAI）の効果的な管理を促進する重要なプログラムです。HAIの一般的な例としては、肺炎、消化器疾患、尿路感染、一次血流感染、術後感染などがあります。HAIの多発は世界各国の政府にとって重大な関心事であり、こうした事態を効果的に管理し減少させることを目的とした政策の策定につながっています。

主な市場促進要因

• 1.院内感染の有病率の増加：院内感染（HAI）の流行増加は、感染監視ソリューションの需要を促進しています。HAIは医療関連感染とも呼ばれ、患者が医療施設で治療を受けている間に感染するものです。これらの感染症は、入院期間の長期化、医療コストの増大、患者の不快感、そして重症の場合は死亡につながることさえあります。このような懸念の高まりを受けて、HAIの予防、監視、管理に役立つ感染監視ソリューションが求められています。

• 2.手術件数の増加：手術件数の増加が感染監視ソリューションの需要を促進しています。手術には術後感染のリスクがあり、合併症、入院期間の延長、医療コストの増加、患者の不快感などにつながる可能性があります。感染監視ソリューションは、外科手術後に発生する感染も含め、HAIを監視・予防する上で重要な役割を果たしています。外科的処置によって病原体が体内に侵入し、手術部位での感染リスクが高まる可能性があります。感染監視ソリューションは、医療施設が手術部位を監視して感染を早期に発見し、迅速な介入につなげるのに役立ちます。
• 3.医療環境全体における政府の取り組みとIPCプログラムへの投資の拡大：世界各国の政府は、長期的な感染予防・管理プログラムを策定し、医療従事者にベストプラクティスを教育するための政策と政策を実施しています。政府は、公的な統計記録を管理するだけでなく、先進的な感染サーベイランス・ソフトウェアを導入するための資金を医療センターや組織に提供しています。こうした取り組みにより、さまざまな規模の医療施設が最先端のツールを効率的に活用できるようになり、感染管理サーベイランス・ソリューション市場の成長に寄与しています。
• 4.AI統合による医療システム改善への投資拡大：医療システムへの投資は、患者の安全とケアの質を優先します。感染監視ソリューションは、HAIの特定と予防に重要な役割を果たし、患者の安全アウトカムの改善に貢献します。医療システムは、HAIを含む有害事象を削減するための品質改善イニシアチブに注力しています。HAIは、入院期間の延長、追加治療、再入院による医療コストの増加につながります。感染監視ソリューションへの投資は、感染とそれに伴う合併症を予防することで、大幅なコスト削減につながります。
• 5.クラウドベースのソフトウェアソリューション：クラウドベースのソフトウェアソリューションは、今後感染監視ソリューション（ISS）市場を大きく押し上げると予想されます。クラウド技術はスケーラビリティ、コスト削減、リモートアクセスの利点を提供し、効率的でスケーラブルな感染監視ソリューションを求める医療機関のニーズに合致しています。
• 6.医療業界における統合の進展：医療業界における統合の増加は、感染サーベイランス・ソリューション（ISS）市場を押し上げると予想されます。

セグメント別洞察

オファリング別洞察：市場はソフトウェアとサービスに分類されます。2022年には、ソフトウェア分野が市場を独占し、サービス分野は予測期間中により高い年間平均成長率（CAGR）を示すと予測されます。ソフトウェア分野の成長は、さまざまな構成での利用可能性、迅速な投資回収、リアルタイム分析などの利点に起因しています。

エンドユーザー別洞察病院が最大の市場シェアを占め、予測期間中に最も高い成長率を示します。手術部位感染（SSI）を含む医療関連感染（HAI）の著しい蔓延が、病院における市場の成長に寄与しています。

• Cerner Corporation
• Epic Systems Corporation
• VigiLanz Corporation
• Becton, Dickinson and Company
• Premier Inc.
• DEB Group Ltd
• RL Solutions
• Baxter International Inc. (ICNet International)
• Gojo Industries Inc.
• IBM Corporation (Truven Health Analytics)

調査範囲

本レポートでは、世界の感染監視ソリューション市場を以下のカテゴリーに分類し、さらに業界動向についても詳述しています。

感染監視ソリューション市場、提供製品別

• ソフトウェア
• サービス

感染監視ソリューション市場：エンドユーザー別

• 病院
• 介護施設

感染監視ソリューション市場：地域別

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• フランス
• 英国
• イタリア
• ドイツ
• スペイン
• アジア太平洋
• 中国
• インド
• 日本
• オーストラリア
• 韓国
• 南米
• ブラジル
• アルゼンチン
• コロンビア
• 中東＆アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦
• クウェート
• トルコ
• エジプト

競合情勢

• 企業プロファイル：世界の感染監視ソリューション市場に参入している主要企業の詳細分析

カスタマイズ

• TechSci Research社は、所定の市場データを使用した世界の感染監視ソリューション市場レポートにおいて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です。

企業情報

• 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 感染監視ソリューションの世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • オファリング別（ソフトウェア、サービス）
  • エンドユーザー別（病院、介護施設）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 北米の感染監視ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • オファリング別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の感染監視ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • オファリング別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の感染監視ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • オファリング別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の感染監視ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • オファリング別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの感染監視ソリューション市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • オファリング別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 世界の感染監視ソリューション市場のSWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Cerner Corporation
• Epic Systems Corporation
• VigiLanz Corporation
• Becton, Dickinson and Company
• Premier Inc.
• DEB Group Ltd
• RL Solutions
• Baxter International Inc.（ICNet International）
• Gojo Industries Inc.
• IBM Corporation（Truven Health Analytics）

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Infection Surveillance Solutions Market has valued at USD 557.21 Million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.86% through 2028. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents.

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control.

The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.

Increasing Number of Surgeries

The increasing number of surgeries is driving the demand for infection surveillance solutions. Surgeries, while often necessary for medical treatment, carry a risk of post-operative infections, which can lead to complications, extended hospital stays, increased healthcare costs, and patient discomfort. Infection surveillance solutions play a critical role in monitoring and preventing healthcare-associated infections (HAIs), including those that occur after surgical procedures. Surgical procedures can introduce pathogens into the body, increasing the risk of infections at the surgical site. Infection surveillance solutions help healthcare facilities monitor surgical sites and detect infections early, leading to prompt interventions. Surgical site infections can lead to complications such as wound dehiscence, sepsis, and prolonged recovery. Effective infection surveillance solutions aid in preventing these complications, improving patient outcomes. Surgeons and healthcare professionals rely on data-driven insights to make informed decisions. Infection surveillance solutions provide real-time data and analytics to monitor infection trends, identify potential outbreaks, and inform clinical decisions. The increasing number of surgeries amplifies the importance of infection surveillance solutions in preventing post-operative infections and improving patient outcomes. As healthcare facilities recognize the impact of infection control on patient safety, quality of care, and financial sustainability, the demand for these solutions is expected to continue to rise.

Growing Government Initiatives & Investment in IPC Programs Across Healthcare Settings

Infection surveillance solutions are utilized in healthcare settings to empower healthcare professionals in predicting and preventing the transmission of infectious diseases. By early detection, evaluating intervention effectiveness, and identifying risk reduction tools, these solutions play a crucial role. Governments worldwide are implementing policies and regulations to develop long-term prevention programs and educate healthcare providers on infection prevention and control best practices. In addition to maintaining public statistical records, governments offer funding to healthcare centers and organizations for advanced infection surveillance software installation. These initiatives enable healthcare facilities of varying sizes to efficiently utilize cutting-edge tools, contributing to the growth of the infection control surveillance solutions market.

Growing Investments to Improve Healthcare Systems by AI integration

Investments in healthcare systems often prioritize patient safety and quality of care. Infection surveillance solutions play a vital role in identifying and preventing healthcare-associated infections (HAIs), thus contributing to improved patient safety outcomes. Healthcare systems are focusing on quality improvement initiatives to reduce adverse events, including HAIs. Infection surveillance solutions provide real-time monitoring, data analysis, and early detection of potential outbreaks, supporting these initiatives. HAIs lead to increased healthcare costs due to prolonged hospital stays, additional treatments, and readmissions. Investments in infection surveillance solutions can lead to significant cost savings by preventing infections and their associated complications.

Cloud-based and AI-integrated infection surveillance and control software is a critical technology that empowers public health organizations to swiftly and effectively detect and respond to infections. Over the years, advancements in cloud-based and AI-integrated software have significantly enhanced the efficacy and efficiency of infection surveillance and control. By leveraging cloud-based solutions, public health organizations can efficiently and securely store and manage large volumes of data. Furthermore, real-time access to this data enables more responsive action during outbreaks. Another notable progress in cloud-based and AI-integrated infection surveillance and control software is the integration of machine learning algorithms. These algorithms enable public health organizations to derive more comprehensive insights from the data, facilitating a better understanding of underlying infection patterns and informed response strategies.

Key Market Challenges

High Cost of Deployment for Small Healthcare Organizations

The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.

Data Security Concerns

Infection surveillance solutions require the collection and storage of patient health data, including personal and medical information. Ensuring the privacy of this data is crucial to maintain patient trust and comply with regulations like the Health Insurance Portability and Accountability Act (HIPAA) in the United States. Healthcare organizations are subject to strict data protection regulations and standards, which can vary by region. Failure to comply with these regulations can lead to severe penalties. Implementing ISS while ensuring compliance adds complexity and cost to the process. The software and hardware used in ISS solutions can have vulnerabilities that hackers could exploit to gain unauthorized access. Addressing these vulnerabilities requires continuous monitoring, updates, and security measures. Many ISS solutions involve third-party vendors and cloud services for data storage and management. This introduces additional security concerns, as healthcare organizations need to trust that these vendors have robust security measures in place.

Key Market Trends

Cloud-based Software Solutions

Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.

Increasing Consolidation in The Healthcare Industry

Increasing consolidation in the healthcare industry is expected to boost the Infection Surveillance Solutions (ISS) market in the future. Healthcare industry consolidation refers to the merging of hospitals, healthcare systems, and medical facilities into larger entities. As healthcare organizations consolidate, there is a greater focus on standardizing practices across different facilities. This includes infection control protocols and the adoption of common technology solutions like ISS to ensure consistent monitoring and management of infections. Consolidated healthcare entities often seek to integrate and share patient data seamlessly. Infection surveillance solutions that offer interoperability and data sharing capabilities are crucial for tracking infections across different departments and locations.

Segmental Insights

Product Type Insights

Based on the offering, the market is categorized into software and services. In 2022, the software segment dominated the market. Conversely, the services segment is projected to demonstrate a higher Compound Annual Growth Rate (CAGR) during the forecast period, owing to the increased adoption of software packages in healthcare facilities. The software segment is expected to witness the highest CAGR throughout the forecast period. This growth can be attributed to its advantages over on-premises software, including availability in different configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT companies are introducing innovative solutions in data management, analytics, and infrastructure, facilitating easier data collection of electronic health records (EHR), infection, and epidemic trends through their software packages.

End User Insights

The infection surveillance solutions market, categorized by end user, is divided into hospitals, and long-term care facilities. Among these, the hospitals segment holds the largest market share and exhibits the highest growth rate during the forecast period. The significant prevalence of healthcare-associated infections (HAIs) and the subsequent financial burden on stakeholders have propelled the adoption of infection control products and services in hospitals. Additionally, the substantial patient volume and the increasing incidence of surgical site infections (SSIs) contribute to the market's growth. Notable HAIs commonly reported in hospitals include central line-associated bloodstream infections, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci bloodstream infections, Clostridium difficile infections, and SSIs.

Regional Insights

The North American region has demonstrated dominance in market share compared to other regions. This can be attributed to strict regulations and the presence of numerous firms offering infection surveillance solutions in the region. The government's substantial investment in healthcare has led to an increase in the number of healthcare centers. On the other hand, the APAC region is experiencing the highest growth rate. This can be attributed to increased health awareness, higher healthcare expenditure, a growing number of healthcare centers, and significant improvements in health insurance.

Key Market Players

• Cerner Corporation

• Epic Systems Corporation

• VigiLanz Corporation

• Becton, Dickinson and Company

• Premier Inc.

• DEB Group Ltd

• RL Solutions

• Baxter International Inc. (ICNet International)

• Gojo Industries Inc.

• IBM Corporation (Truven Health Analytics)

Report Scope:

In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Surveillance Solutions Market, By Offering:

• Software
• Service

Infection Surveillance Solutions Market, By End User:

• Hospitals
• Long-term Care Facilities

Infection Surveillance Solutions Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Available Customizations:

• Global Infection Surveillance Solutions market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Offering (Software, Service)
  • 5.2.2. By End User (Hospitals, Long-term Care Facilities)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map

6. North America Infection Surveillance Solutions Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Offering
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Infection Surveillance Solutions Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Offering
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Infection Surveillance Solutions Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Offering
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Infection Surveillance Solutions Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Offering
      • 6.3.3.2.2. By End User

7. Europe Infection Surveillance Solutions Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Offering
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Infection Surveillance Solutions Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Offering
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Infection Surveillance Solutions Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Offering
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Infection Surveillance Solutions Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Offering
      • 7.3.3.2.2. By End User
  • 7.3.4. France Infection Surveillance Solutions Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Offering
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Infection Surveillance Solutions Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Offering
      • 7.3.5.2.2. By End User

8. Asia-Pacific Infection Surveillance Solutions Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Offering
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Infection Surveillance Solutions Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Offering
      • 8.3.1.2.2. By End User
  • 8.3.2. India Infection Surveillance Solutions Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Offering
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Infection Surveillance Solutions Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Offering
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Infection Surveillance Solutions Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Offering
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Infection Surveillance Solutions Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Offering
      • 8.3.5.2.2. By End User

9. South America Infection Surveillance Solutions Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Offering
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Infection Surveillance Solutions Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Offering
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Infection Surveillance Solutions Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Offering
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Infection Surveillance Solutions Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Offering
      • 9.3.3.2.2. By End User

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Offering
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Infection Surveillance Solutions Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Offering
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Infection Surveillance Solutions Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Offering
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Infection Surveillance Solutions Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Offering
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Infection Surveillance Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Cerner Corporation
  • 15.5.2. Epic Systems Corporation
  • 15.5.3. VigiLanz Corporation
  • 15.5.4. Becton, Dickinson and Company
  • 15.5.5. Premier Inc.
  • 15.5.6. DEB Group Ltd
  • 15.5.7. RL Solutions
  • 15.5.8. Baxter International Inc. (ICNet International)
  • 15.5.9. Gojo Industries Inc.
  • 15.5.10. IBM Corporation (Truven Health Analytics)

16. Strategic Recommendations

17. About Us & Disclaimer